Managing Hypertension with Ambulatory Blood Pressure Monitoring

Current Cardiology Reports

Volumn 17, Issue 2, 2015, Pages 1-9

  White, William B ^a   Gulati, Vinay ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Ambulatory blood pressure; Blood pressure variability; Cardiovascular risk; Masked hypertension; Morning surge; Nocturnal hypertension; White coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CIRCADIAN RHYTHM; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL PRACTICE; DIASTOLIC BLOOD PRESSURE; HOME MONITORING; HUMAN; HYPERTENSION; MASKED HYPERTENSION; REVIEW; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PROSPECTIVE STUDY;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES;

EID: 84921480059     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-014-0556-6     Document Type: Review

References (83)

1. Pickering TG, White WB. When and how to use self (home) and ambulatory blood pressure monitoring. J Am Soc Hypertens. 2010;4:56–61. Consensus document on clinical and practical recommendations for using home and ambulatory blood pressure monitoring.
2. Mancia G, Fagard R, Narkiewicz K, Task Force Members, et al. 2013 ESH/ ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357. Consensus guidelines document of the ESH/ESC on management of hypertension.
3. Pickering T. Recommendations for the use of home (self) and ambulatory blood pressure monitoring. American Society of Hypertension Ad Hoc Panel. Am J Hypertens. 1996;9:1–11.
4. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation. 2005;111:697–716.
5. Williams B, Poulter NR, Brown MJ, et al. Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens. 2004;18:139–85.
6. World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999, 17:151–183.
7. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–72.
8. Clement DL, De Buyzere ML, De Bacquer DA, et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med. 2003;348:2407–15.
9. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory over clinic blood pressure measurement in predicting mortality: the Dublin outcome study. Hypertension. 2005;46:156–61.
10. CMS.gov. Centers for Medicare & Medicaid Services. Medicare coverage policy decisions. ABPM monitoring (#CAG-00067N). 2001. http://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=5&NcaName=Ambulatory+Blood+Pressure+Monitoring&ver=9&from=%252527lmrpstate%252527&contractor=22&name=CIGNA+Government+Services+(05535)+-+Carrier&letter_range=4&bc=gCAAAAAAIAAA. Assessed July 1 2014.
11. National Institute for Health and Clinical Excellence (NICE). Hypertension: the clinical management of primary hypertension in adults. Clinical Guideline 127. 2011. www.nice.org.uk/guidance/CG127. Assessed July 1 2014.
12. O’Brien E, Parati G, Stergiou G, The European Society of Hypertension Working Group on Blood Pressure Monitoring, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–67. Consensus document on fundamentals and recommendations for ABPM.
13. O’Brien E, Parati G, Stergiou G, et al. Ambulatory blood pressure measurement: what is the international consensus? Hypertension. 2013;62:988–94. Summary of the consensus document of ESH emphasizing clinically relevant issues in the use of ABPM.
14. Bloch MJ, Basile JN. New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States. J Clin Hypertens (Greenwich). 2011;13:785–6.
15. Krause T, Lovibond K, Caulfield M, et al. Management of hypertension: summary of NICE guidance. BMJ. 2011;343:d4891. An important summary of the updated NICE guidelines on the management of hypertension and one of the first evidence to support using ambulatory blood pressure monitoring in clinical practice.
16. White WB. Ambulatory blood-pressure monitoring in clinical practice. N Engl J Med. 2003;348:2377–8.
17. White WB. Circadian variation of blood pressure: clinical relevance and implications for cardiovascular chronotherapeutics. Blood Press Monit. 1997;2:47–51.
18. Hermida RC, Smolensky MH, Ayala DE, et al. 2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. Chronobiol Int. 2013;30:3,355–410.
19. Sundberg S, Kohvakka A, Gordin A. Rapid reversal of circadian blood pressure rhythm in shift workers. J Hypertens. 1988;6:393–6.
20. Sternberg H, Rosenthal T, Shamiss A, Green M. Altered circadian rhythm of blood pressure in shift workers. J Hum Hypertens. 1995;9:349–53.
21. White WB, Mansoor GA, Tendler BE, Anwar YA. Nocturnal blood pressure epidemiology, determinants, and effects of antihypertensive therapy. Blood Press Monit. 1998;3:43–51.
22. Di Iorio A, Marini E, Lupinetti M, Zito M, Abate G. Blood pressure rhythm and prevalence of vascular events in hypertensive subjects. Age Ageing. 1999;28:23–8.
23. Sherwood A, Thurston R, Steffen P, et al. Blunted nighttime blood pressure dipping in postmenopausal women. Am J Hypertens. 2001;14:749–54.
24. Harshfield GA, Hwang C, Grim CE. Circadian variation of blood pressure in blacks: influence of age, gender and activity. J Hum Hypertens. 1990;4:43–7.
25. Cuspidi C, Giudici V, Negri F, Sala C. Nocturnal nondipping and left ventricular hypertrophy in hypertension: an updated review. Expert Rev Cardiovasc Ther. 2010;8:781–92.
26. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressure monitoring. N Engl J Med. 2006;354:2368–74.
27. Fan HQ, Li Y, Thijs L, et al. Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens. 2010;28:2036–45.
28. Boggia J, Li Y, Thijs L, et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet. 2007;370:1219–29.
29. Brotman DJ, Davidson MB, Boumitri M, et al. Impaired diurnal blood pressure variation and all-cause mortality. Am J Hypertens. 2008;21:92–7.
30. Hermida RC, Ayala DE, Fernandez JR, et al. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int. 2013;30:68–86.
31. White WB, Larocca GM. Improving the utility of the nocturnal hypertension definition by using absolute sleep blood pressure rather than the “dipping” proportion. Am J Cardiol. 2003;92:1439–41.
32. Mochizuki Y, Okutani M, Donfeng Y, et al. Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens. 1998;11:403–9.
33. Omboni S, Parati G, Palatini P, et al. Reproducibility and clinical value of nocturnal hypotension: prospective evidence from the SAMPLE study. Study on Ambulatory Monitoring of Pressure and Lisinopril Evaluation. J Hypertens. 1998;16:733–8.
34. Ohkubo T, Hozawa A, Yamaguchi J, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. Hypertension. 2002;20:2183–9.
35. Gorostidi M, Sobrino J, Segura J, et al. Ambulatory blood pressure monitoring in hypertensive patients with high cardiovascular risk: a cross-sectional analysis of a 20,000-patient database in Spain. J Hypertens. 2007;25:977–84.
36. de la Sierra A, Segura J, Gorostidi M, et al. Diurnal blood pressure variation, risk categories and antihypertensive treatment. Hypertens Res. 2010;33:767–71.
37. de la Sierra A, Redon J, Banegas JR, et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension. 2009;53:466–72.
38. Cuspidi C, Macca G, Sampieri L, et al. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens. 2001;19:1539–45.
39. Verdecchia P. Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension. 2000;35:844–51.
40. Kario K, White WB. Early morning hypertension: what does it contribute to overall cardiovascular risk assessment? J Am Soc Hypertens. 2008;2:397–402.
41. White WB. Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press Monit. 2001;6:63–72.
42. Wroe SJ, Sandercock P, Bamford J, et al. Diurnal variation in incidence of stroke: Oxfordshire community stroke project. BMJ. 1992;304:155–7.
43. Elliott WJ. Circadian variation in the timing of stroke onset: a meta-analysis. Stroke. 1998;29:992–6.
44. Casetta I, Granieri E, Portaluppi F, Manfredini R. Circadian variability in hemorrhagic stroke. JAMA. 2002;287:1266–7.
45. Gallerani M, Manfredini R, Ricci L, et al. Chronobiological aspects of acute cerebrovascular diseases. Acta Neurol Scand. 1993;87:482–7.
46. Kario K, Pickering TG, Umeda Y, et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation. 2003;107:1401–6.
47. Metoki H, Ohkubo T, Kikuya M, et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension. 2006;47:149–54.
48. Li Y, Thijs L, Hansen TW, et al. Prognostic value of the morning blood pressure surge in 5645 subjects from 8 populations. Hypertension. 2010;55:1040–8.
49. White WB. Importance of blood pressure control over a 24-hour period. J Manag Care Pharm. 2007;13(Suppl B):34–9.
50. Hermida RC, Ayala DE, Mojon A, et al. Influence of time of day of blood pressure-lowering treatment on cardiovascular risk in hypertensive patients with type 2 diabetes. Diabetes Care. 2011;34:1270–6.
51. Myers MG, Reeves RA. White coat phenomenon in patients receiving antihypertensive therapy. Am J Hypertens. 1991;4:844–9.
52. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens. 2007;25:2193–8.
53. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens. 2011;24:52–8.
54. Mancia G, Bombelli M, Facchetti R, et al. Long term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009;54:226–32.
55. Franklin SS, Thijs L, Hansen TW, International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension. 2012;59:564–71.
56. Bjorklund K, Lind L, Vessby B, et al. Different metabolic predictors of white-coat and sustained hypertension over a 20-year follow-up period: a population-based study of elderly men. Circulation. 2002;106:63–8.
57. Sander GE, Giles TD. Resistant hypertension: concepts and approach to management. Curr Hypertens Rep. 2011;13:347–55.
58. O’Brien E, Coats A, Owens P, et al. Use and interpretation of ambulatory blood pressure monitoring; recommendations of the British Hypertension Society. BMJ. 2000;320:1128–34.
59. Yano Y, Bakris GL. Recognition and management of masked hypertension: a review and novel approach. J Am Soc Hypertens. 2013;7:244–52.
60. Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens. 2005;18:772–8.
61. Pickering T, Davidson K, Gerin W, et al. Masked hypertension. Hypertension. 2002;40:795–6.
62. Liu JE, Roman MJ, Pini R, et al. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med. 1999;131:564–72.
63. Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R. Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens. 2010;23:1190–7. Illustrates that home blood pressure monitoring may not be adequate to detect masked hypertension.
64. Verberk WJ, Kessels AG, de Leeuw PW. Prevalence, causes, and consequences of masked hypertension: a meta-analysis. Am J Hypertens. 2008;21:969–75.
65. Hodgkinson J, Mant J, Martin U, et al. Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ. 2011;342:d3621.
66. Perloff D, Sokolow M, Cowan R. The prognostic value of ambulatory blood pressures. JAMA. 1983;249:2792–8.
67. Fagard RH, Staessen JA, Thijs L, et al. Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation. 2000;102:1139–44.
68. Staessen JA, Thijs L, Fagard R, et al. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators. JAMA. 1999;282:539–46.
69. Mancia G, Facchetti R, Bombelli M, et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846–53.
70. Minutolo R, Agarwal R, Borrelli S, et al. Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med. 2011;171:1090–8. Demonstrates the importance and utility of using ambulatory blood pressure monitoring in patients with chronic kidney disease as it relates to cardiovascular and renal outcomes.
71. Neutel JM. The importance of 24-h blood pressure control. Blood Press Monit. 2001;6:9–16.
72. White WB, Lacourciere Y, Davidai G. Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period. Am J Hypertens. 2004;17:347–53.
73. O’Brien E. The value of 24-h blood pressure monitoring to assess the efficacy of antihypertensive drug treatment. Hot Topics Hypertens. 2011;4:7–23.
74. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Influence of circadian time of hypertension treatment on cardiovascular risk: results of the MAPEC study. Chronobiol Int. 2010;27:1629–51. This article provides information on the effect of timing of hypertension treatment using ambulatory blood pressure monitoring and actigraphy.
75. Mancia G, Parati G. Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis. J Hypertens. 2004;22:435–45.
76. Graves JW, Nash C, Burger K, Bailey K, Sheps SG. Clinical decision-making in hypertension using an automated (BpTRU) measurement device. J Hum Hypertens. 2003;17:823–7.
77. Pickering TG, Miller NH, Ogedegbe G, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. J Am Soc Hypertens. 2008;2:192–202.
78. Mule G, Caimi G, Cottone S, et al. Value of home blood pressures as predictor of target organ damage in mild arterial hypertension. J Cardiovasc Risk. 2002;9:123–9.
79. Tachibana R, Tabara Y, Kondo I, Miki T, Kohara K. Home blood pressure is a better predictor of carotid atherosclerosis than office blood pressure in community-dwelling subjects. Hypertens Res. 2004;27:633–9.
80. Ohkubo T, Imai Y, Tsuji I, et al. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens. 1998;16:971–5.
81. Sega R, Facchetti R, Bombelli M, et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation. 2005;111:1777–83.
82. Agarwal R, Andersen MJ. Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int. 2006;69:406–11.
83. White WB, Maraka S. Is it possible to manage hypertension and evaluate therapy without ambulatory blood pressure monitoring? Curr Hypertens Rep. 2012;14:366–73.